(1)
Chandra, A. . Identification of Biorelevant Dissolution Media to Assess Biopharmaceutical Performance of Erlotinib Formulation With Enhanced Bioavailability Using Physiologybased Pharmacokinetic Modeling. AJP 2022, 16.